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The original version of this article unfortunately con-
tained a typographical mistake. In the title of the article, 
as well as in the body and backmatter of the article, the 
word ‘phosphate’ was used where ‘phosphatase’ should 
have been used. Please find below the instances where 
‘phosphatase’ should replace ‘phosphate’ in the original 
article.
Title
A novel placental like alkaline phosphatase promoter 
driven transcriptional silencing combined with single 
chain variable fragment antibody based virosomal deliv-
ery for neoplastic cell targeting
Abstract
Placental like alkaline phosphatase (PLAP), an oncofetal 
antigen, is highly expressed in germ cell, cervical, ovarian 
and several other tumour types but minimally in normal 
tissues. The expression of a PLAP promoter based tran-
scriptional unit following antigen mediated cell specific 
delivery is a possible approach for tumour targeting.
Keywords
Placental like alkaline phosphatase
Germ cell alkaline phosphatase (GCAP)
Introduction
We reasoned that combining an antibody based targeting 
modality with a construct based on antigen’s own pro-
moter would provide a novel way for increasing tumour 
specificity and efficacy. Our laboratory has been work-
ing on distinct but immunologically identical oncofetal 
isozymes of alkaline phosphatases (APs); the placental 
alkaline phosphatase (PAP) and placental like alkaline 
phosphatase (PLAP).
Discussion
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